A mobile app–based program for facilitating advance care planning discussions between patients with advanced cancer and oncologists: A randomized controlled trial (J-SUPPORT 2104). This is an ASCO ...
MiniMed Group, Inc. MMED recently announced results from a new randomized crossover study showing that glycemic outcomes remained nearly identical when patients used its MiniMed 780G automated insulin ...
現在アクセス不可の可能性がある結果が表示されています。
アクセス不可の結果を非表示にする